AMIX
NASD Autonomix Medical, Inc.$3.19 ↑ +0.18 (+5.98%) Trading Up from the previous close of $3.01
- YTD change
- -72.38%
- vs 20-day SMA
- -14.64%
- vs 200-day SMA
- -56.61%
Price ranges
Price & Performance
+2.61 (+661.25%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.9% away from all-time highs of $3,192.00
- AMIX is down 72% since the beginning of the year
- AMIX is down 87% over the past 12 months
- AMIX is down 24% over the past 1 month
- 1% of all AMIX investors are betting against AMIX
AMIX reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +164.0%.
- Previous minute
- +$0.00
- Last hour
- +$0.01
- Last 5 days
- -8.07%
- vs 8-day SMA
- -3.88%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies. The company was founded by Robert Schwartz, Landy Toth, David A. Robins, and Robert A. Van Tassel on June 10, 2014 and is headquartered in The Woodlands, TX.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
